Loading...
AXIM Biotechnologies, Inc.
AXIM•PNK
Healthcare
Biotechnology
$0.007
$0.001(16.28%)
AXIM Biotechnologies, Inc. (AXIM) Financial Performance & Statements
Review AXIM Biotechnologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
78.29%
↑ 78.29%
Operating Income Growth
35.91%
↑ 35.91%
Net Income Growth
56.42%
↑ 56.42%
Operating Cash Flow Growth
17.02%
↑ 17.02%
Operating Margin
-2506.28%
↓ 2506.28%
Gross Margin
-370.64%
↓ 370.64%
Net Profit Margin
-4985.19%
↓ 4985.19%
ROE
37.56%
↑ 37.56%
ROIC
53.27%
↑ 53.27%
AXIM Biotechnologies, Inc. (AXIM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for AXIM Biotechnologies, Inc. stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $70458.00 | $39518.00 | $8875.00 | $60460.00 |
| Cost of Revenue | $439731.00 | $0.00 | $426126.00 | $0.00 |
| Gross Profit | -$369273.00 | $39518.00 | -$417251.00 | $60460.00 |
| Gross Profit Ratio | -$5.24 | $1.00 | -$47.01 | $1.00 |
| R&D Expenses | $39823.00 | $125496.00 | $153697.00 | $284869.00 |
| SG&A Expenses | $1.35M | $2.24M | $4.08M | $5.67M |
| Operating Expenses | $1.39M | $2.79M | $4.66M | $7.79M |
| Total Costs & Expenses | -$1.83M | $2.79M | $4.66M | $7.79M |
| Interest Income | $0.00 | $0.00 | $257.00 | $1026.00 |
| Interest Expense | $636158.00 | $1.20M | $1.88M | $485825.00 |
| Depreciation & Amortization | $432394.00 | $427019.00 | $426126.00 | $2.12M |
| EBITDA | -$2.44M | -$6.43M | -$3.94M | -$13.17M |
| EBITDA Ratio | -$34.69 | -$162.66 | -$476.21 | -$97.08 |
| Operating Income | -$1.76M | -$2.75M | -$4.65M | -$7.99M |
| Operating Income Ratio | -$25.02 | -$69.61 | -$524.26 | -$132.07 |
| Other Income/Expenses (Net) | -$1.75M | -$5.31M | -$1.59M | -$2.05M |
| Income Before Tax | -$3.51M | -$8.06M | -$6.24M | -$16.02M |
| Income Before Tax Ratio | -$49.85 | -$203.95 | -$703.43 | -$265.04 |
| Income Tax Expense | $0.00 | $0.00 | -$285983.00 | $493821.00 |
| Net Income | -$3.51M | -$8.06M | -$5.96M | -$16.52M |
| Net Income Ratio | -$49.85 | -$203.95 | -$671.21 | -$273.21 |
| EPS | -$0.01 | -$0.04 | -$0.04 | -$0.13 |
| Diluted EPS | -$0.01 | -$0.04 | -$0.04 | -$0.13 |
| Weighted Avg Shares Outstanding | $318.90M | $227.69M | $165.47M | $131.54M |
| Weighted Avg Shares Outstanding (Diluted) | $318.90M | $227.69M | $165.47M | $131.54M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan